Langerhans cell density and serological changes following intradermal immunisation of mice with dengue 2 virus

Journal of Medical Microbiology

Volumn 45, Issue 2, 1996, Pages 138-145

  Taweechaisupapong, Suwimol ^a   Sriurairatana, Siriporn ^b   Angsubhakorn, Subhkij ^a   Yoksan, Sutee ^a   Khin, Mi Mi ^a   Sahaphong, Somphong ^a   Bhamarapravati, Natth ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DENGUE; DENGUE VIRUS; IMMUNIZATION; IMMUNOMODULATION; LANGERHANS CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0029780274     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/00222615-45-2-138     Document Type: Article

References (38)

1. Stanfield JP, Bracken PM, Waddell KM, Gall D. Diphtheria-tetanus-pertussis immunization by intradermal jet injection. BMJ 1972; 2: 197-199.
2. Anonymous, A controlled field trial on the effectiveness of the intradermal and subcutaneous administration of cholera vaccine in the Philippines. Bull World Health Organ 1973; 49: 389-394.
3. Anonymous. A comparison of intradermal BCG vaccination by let injection and by syringe and needle. Tubercle 1971; 52: 155-165.
4. Payler DK, Skirrow MB. Intradermal influenza vaccination. BMJ 1974; 2: 727.
5. Ubol S, Phanuphak P. An effective economical intradermal regimen of human diploid cell rabies vaccination for post-exposure treatment. Clin Exp Immunol 1986; 63: 491-497.
6. Briggs DJ, Schwenke JR. Longevity of rabies antibody titres in recipients of human diploid cell rabies vaccine. Vaccine 1992; 10: 125-129.
7. Bryan JP, Sjogren MH, Perine PL, Legters LJ. Low-dose intradermal and intramuscular vaccination against hepatitis B. Clin Infect Dis 1992; 14: 697-707.
8. Katz SI, Cooper KD, Iijima M, Tsuchida T. The role of Langerhans cells in antigen presentation. J Invest Dermatol 1985: 85(1 Suppl): 96s-98s.
9. Braathen LR, Thorsby E. Studies on human epidermal Langerhans cells. I. Allo-activating and antigen-presenting capacity. Scand J Immunol 1980; 11: 401-408.
10. Hayashi Y, Aurelian L. Immunity to herpes simplex virus type 2: viral antigen-presenting capacity of epidermal cells and its impairment by ultraviolet irradiation. J Immunol 1986; 136: 1087-1092.
11. Shelley WB, Juhlin L. Langerhans cells form a reticulo-epithelial trap for external contact antigens. Nature 1976; 261: 46-47.
12. Nagao S, Inaba S, Iijima S. Langerhans cells at the sites of vaccinia virus inoculation. Arch Dermatol Res 1976; 256: 23-31.
13. Sprecher L, Becker Y. Langerhans cell density and activity in mouse skin and lymph nodes affect herpes simplex type I (HSV-1) pathogenicity. Arch Virol 1989; 107: 191-205.
14. Halstead SB. Pathogenesis of dengue: challenges to molecular biology. Science 1988; 239: 476-481.
15. Halstead SB, Udomsakdi S, Simasthien P, Singharaj P, Sukhavachana P, Nisalak A. Observations related to pathogenesis of dengue hemorrhagic fever. I. Experience with classification of dengue viruses. Yale J Biol Med 1970; 42: 261-275.
16. Russell PK, Nisalak A, Sukhavachana P, Vivona S. A plaque reduction lest for dengue virus neutralizing antibodies. J Immunol 1967; 99: 285-290.
17. Scaletta LJ, MacCallum DK. A fine structural study of divalent cation-mediated epithelial union with connective tissue in human oral mucosa. Am J Anal 1972; 133: 431-153.
18. Mackenzie IC, Squier CA. Cytochemical identification of ATPase-positive Langerhans cells in EDTA-separated sheets of mouse epidermis. Br J Dermatol 1975; 92: 523-533.
19. Kuberski TT, Rosen L. A simple technique for the detection of dengue antigen in mosquitoes by immunofluorescence. Am J Trop Med Hyg 1977; 26: 533-537.
20. Trump BF, Smuckler EA, Benditt EP. A method for staining ecpoxy sections tor light microscopy. J Ultrastruct Res 1961; 5: 343-348.
21. Larsen CP, Steinman RM, Winner-Pack M, Hankins DF, Morris PJ, Austyn JM. Migration and maturation of Langerhans cells in skin transplants and explants. J Exp Med 1990; 172: 1483-1493.
22. Silberberg-Sinakin I, Thorbecke GJ, Baer RL, Rosenthal SA, Berezowsky V. Antigen-hearing Langerhans cells in skin, dermal lymphatics and in lymph nodes. Cell Immunol 1976; 25: 137-151.
23. Katz SI, Tamaki K, Sachs DH. Epidermal Langerhans cells are derived from cells originating in hone marrow. Nature 1979; 282: 324-326.
24. Ioffreda MD, Whitaker D, Murphy GF. Mast cells degranulation upregulates alpha 6 integrins on epidermal Langerhans cells. J Invest Dermatol 1993; 101: 150-154.
25. Kimber I, Cumberbatch M. Stimulation of Langerhans cell migration by tumor necrosis factor alpha (TNF-alpha). J Invest Dermatol 1992; 99 Suppl: 48s-50s.
26. Staquet M-J, Levarlet B, Dezutter-Dambuyant C, Schmitt D. Human epidermal Langerhans cells express beta 1 integrins that mediate their adhesion to laminin and fibronectin. J Invest Dermatol 1992; 99 Suppl: 12s-14s.
27. Bergstresser PR, Toews GB, Streilein JW. Natural and perturbed distributions of Langerhans cells: responses to ultraviolet light, heterotopic skin grafting and dinitrofluorobenzene sensitization. J Invest Dermatol 1980; 75: 73-77.
28. Botham PA, Rattray NJ, Walsh ST, Riley EJ. Control of the immune response to contact sensitizing chemicals by cutaneous antigen-presenting cells. Br J Dematol 1987; 117: 1-9.
29. Weinlich G, Sepp N, Koch F, Schuler G, Romani N. Evidence that Langerhans cells rapidly disappear from the epidermis in response to contact sensitizers but not to tolerogens/ nonsensitizers. Arch Dermatol Res 1989; 281: 556.
30. Kinnaird A, Peters SW, Foster JR, Kimber I. Dendritic cell accumulation in draining lymph nodes during the induction phase of contact allergy in mice. Int Arch Allergy Appl Immunol 1989; 89: 202-210.
31. Macatonia SE, Knight SC, Edwards AJ, Griffiths S, Fryer P. Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. Functional and morphological studies. J Exp Mat 1987; 166: 1654-1667.
32. Kripke ML, Munn CG, Jeevan A, Tang J-M, Bucana C. Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization. J Immunol 1990; 145: 2833-2838.
33. Neefjes JJ, Ploegh HL. Intracellular transport of MHC class II molecules. Immunol Today 1992; 13: 179-184.
34. Szakal AK, Kosco MH, Tew JG. Microanatomy of lymphoid tissue during humoral immune responses: structure function relationships. Annu Rev Immunol 1989; 7: 91-109.
35. Tew JG, DiLosa RM, Burton GF et al. Germinal centers and antibody production in bone marrow. Immunolo Rev 1992; 126: 99-112.
36. Cahill RNP, Frost H, Trnka Z. The effects of antigen on the migration of recirculating lymphocytes through single lymph nodes. J Exp Med 1976; 143: 870-888.
37. Hay JB, Johnston MG, Vadas P, Chin W, Issekutz T, Movat HZ. Relationships between changes in blood flow and lymphocyte migration induced by antigen. Monogr Allergy 1980; 16: 112-125.
38. Tew JG, Kosco MH, Szakal AK. The alternative antigen pathway. Immunol Today 1989; 10: 229-232.